Total Results: 16081
The budget for the Health and Human Services Department, which was briefly posted online and then removed, shows deep cuts to a variety of health care programs. The National Institutes of Health and the Food and Drug Administration would also be strongly impacted.
Cada vez más los padres indocumentados que tienen hijos con discapacidades severas consultan a abogados y médicos con una pregunta angustiante: cómo evitar la deportación para seguir cuidando de sus niños.
Anticipating a broader immigration crackdown, undocumented families are hiring lawyers and scrambling to make contingency plans for their seriously ill U.S.-born kids.
A new study finds that access to cutting-edge medical technology and well-trained doctors don’t necessarily correlate to good health for a country.
“Over time, per capita caps could significantly reduce the amount of funding that goes towards Medicaid coverage for children,” says Dan Mendelson, president of Avalere, the consulting firm that conducted the study. Meanwhile, in the Senate, Republican moderates float ideas in order to retain Medicaid expansion that could have other consequences for states.
A look at how and why strategic, star-studded advertising brought a drug for a little-known neurological condition into your home.
The Republican health plan would require insurers to offer coverage to people who have preexisting medical conditions. But if states opt to allow insurers to charge sick people more than healthy ones, people who have been more than 63 days without coverage could see significantly higher insurance costs.
White House budget director Mick Mulvaney says that the administration is looking at ways to make drugmakers pay for mandatory rebates on medications bought through Medicare, as done with Medicaid. And Health and Human Services Secretary Tom Price will hold listening sessions on the issue in the coming weeks.
In two interviews, the president reveals some surprising views of health policy.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
The early indications from insurers suggest that premiums for plans sold on the health law’s marketplaces will rise on average again next year. Meanwhile, in an interview with the Economist, President Donald Trump talks about the cost-sharing subsidies that the federal government pays insurers to help cover expenses of low-income customers, saying “we don’t have to subsidize” Obamacare. “You know if I ever stop wanting to pay the subsidies, which I will,” Trump said. “Anytime I want.”
The larger an area’s population, the more likely insurers will compete in that market, according to an Urban Institute analysis.
Opinion writers offer views on how to move forward in efforts to reform the nation’s health care system, including thoughts on what’s right in Obamacare, specific ways its shortcomings need to be addressed and deep problems in the GOP’s American Health Care Act.
A group of international health experts says that fewer than 15 percent of patients feel an improvement in pain and function three months after the procedure — which is the world’s most common surgery — and that those effects usually disappear after one year.
Writing in the journal BMJ, an international group of experts and patients say arthroscopic surgery on the knee does not provide lasting relief.
Un panel internacional desafió la eficacia de uno de los procedimientos ortopédicos más comunes y recomendó fuertemente no realizar la cirugía artroscópica en pacientes con problemas degenerativos de rodilla.
News outlets’ editorial sections highlight policy issues in play as the debate over the GOP health plan continues.
Despite an industry-backed push for more people to be screened for thyroid cancer, the U.S. Preventive Services Task Force has added the option to its don’t-do-it category. In other public health news: pain relievers and heart risks, statins, syphilis, mental health care for children, and smoking.
Problems with 71 of the 222 drugs approved in the first decade of this millennium were discovered after the drugs were approved, according to a new study. Those “safety events” warranted a “black box” warning on side effects or a safety announcement about the dangers.
What will happen to people with preexisting conditions is one worry some Americans expressed; the high costs of insurance under Obamacare is another.